Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shanghai Boxun Medical Biological Instrument Operating Margin %?
Shanghai Boxun Medical Biological InstrumentBJSE:920504 69 Operating Margin % is 9.96% as of Mar. 2026, which is 30% below its 10-year median of 14.16. GuruFocus rates BJSE:920504 with a GF Score™ of 69/100 and a GF Value™ of ¥19.47 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Shanghai Boxun Medical Biological Instrument ranks better than 75.34% on this metric.
BJSE:920504'
s Operating Margin % Range Over the Past 10 Years
Min: 9.65 Med: 14.16 Max: 21.5
Current: 13.74
BJSE:920504's Operating Margin % is ranked better than 75.34% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 3.39
vs BJSE:920504: 13.74
Shanghai Boxun Medical Biological Instrument (BJSE:920504) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Shanghai Boxun Medical Biological Instrument Operating Margin % Related Terms
Shanghai Boxun Medical Biological Instrument Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument Operating Margin % Chart
Shanghai Boxun Medical Biological Instrument Annual Data
BJSE:920504 vs ISRG, BDX, MDLN: Operating Margin % Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Boxun Medical Biological Instrument Operating Margin % vs Medical Devices & Instruments Industry
Shanghai Boxun Medical Biological Instrument Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a Operating Margin % of 9.96% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. This is 30% below median its historical median of 14.16. Over the past decade, Shanghai Boxun Medical Biological Instrument's Operating Margin % has ranged from 9.65 to 21.50. According to the industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #201 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 24.7%.
Is Shanghai Boxun Medical Biological Instrument's Operating Margin % too high?
Shanghai Boxun Medical Biological Instrument's current Operating Margin % of 9.96% is 30% below median its 10-year median of 14.16. Over the past 10 years, this metric has ranged from a low of 9.65 to a high of 21.50. The Medical Devices & Instruments industry median Operating Margin % is 3.39. Shanghai Boxun Medical Biological Instrument's value of 9.96% is 193.8% above this industry median. Based on the distribution chart, Shanghai Boxun Medical Biological Instrument ranks #201 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #201 out of 815 companies for Operating Margin %. This places Shanghai Boxun Medical Biological Instrument in the top 25% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.39. Shanghai Boxun Medical Biological Instrument's value of 9.96% is 193.8% above this benchmark. Historically, Shanghai Boxun Medical Biological Instrument's own Operating Margin % has ranged from 9.65 to 21.50 over the past decade. While the company's 10-year median is 14.16 vs. the industry median of 3.39, Shanghai Boxun Medical Biological Instrument has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.39, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Boxun Medical Biological Instrument's current Operating Margin % of 9.96% is 193.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Boxun Medical Biological Instrument's current Operating Margin % is 9.96%, which is 30% below median its own 10-year median of 14.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.47, compared to a current price of ¥17.11 — trading 12.1% below its estimated fair value. The current Operating Margin % is 9.96%, which is 30% below median its 10-year median of 14.16 and 193.8% above the Medical Devices & Instruments industry median of 3.39. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current Operating Margin % is 9.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued.
The current stock price of ¥17.11 is trading 12.1% below its estimated GF Value™ of ¥19.47.
GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Modestly Undervalued.
Key valuation signals for BJSE:920504:
Operating Margin %: 9.96% (30% below median its 10-year median of 14.16)
GF Value™: ¥19.47 vs. price of ¥17.11 (12.1% below fair value)
Industry Position: 193.8% above the Medical Devices & Instruments median (#201 of 815)
No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score
Get the complete analysis for BJSE:920504
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920504 has been successfully added to your 
